Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.47 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.43 |
| ▸ | CTRC | Q99895 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | EPHX2 | P34913 | 1/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.42 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.41 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.38 |
| ▸ | ELANE | P08246 | 3/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | CDC25A | P30304 | 1/20 | 0.38 |
| ▸ | CDC25B | P30305 | 1/20 | 0.38 |
| ▸ | CDC25C | P30307 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5311171 | 1.00 | MAPT (0.47) | MAPTGPR84CTRCSMN1; SMN2EPHX2 | |
| SCHEMBL11774947 | 0.98 | MAPT (0.50) | MAPTGPR84CTRCSMN1; SMN2EPHX2 | |
| SCHEMBL11322723 | 0.94 | CTRC (0.49) | MAPTGPR84CTRCSMN1; SMN2EPHX2 | |
| SCHEMBL21024529 | 0.87 | EPHX2 (0.50) | MAPTEPHX2ELANECDC25ACDC25B | |
| SCHEMBL981554 | 0.86 | CYP2A6 (0.41) | MAPTCTRCSMN1; SMN2ALOX15CYP2A6 | |
| SCHEMBL8807402 | 0.79 | HTR2B (0.47) | MAPTSMN1; SMN2TDP1L3MBTL1 | |
| Viridepyronone SCHEMBL18270619 | 0.78 | ALDH1A1 (0.40) | MAPTCTRCSMN1; SMN2EPHX2TDP1 | |
| SCHEMBL979708 | 0.77 | — | — | |
| SCHEMBL3394938 | 0.77 | EPHX2 (0.54) | MAPTCTRCEPHX2ALOX15KCNH2 | |
| SCHEMBL26218811 | 0.76 | MEN1 (0.44) | MAPTELANE |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 488 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3452435-B1 | HIGHLY EFFECTIVE AND MULTIFUNCTIONAL MICROBIAL COMPOSITIONS AND USES | ADVANCED BIOLOGICAL MARKETING INC (US) | 2026-03-25 | — | — | EP | claimed |
| US-12575585-B2 | Crumb chocolate flavor compositions | MARS, INCORPORATED (US) | 2026-03-17 | — | — | US | claimed |
| EP-3911795-B1 | METHOD OF STRENGTHENING NON-KERATINOUS FIBERS, AND USES THEREOF | ISP INVESTMENTS LLC (US) | 2025-10-01 | — | — | EP | claimed |
| EP-3383192-B2 | CRUMB CHOCOLATE FLAVOR COMPOSITIONS | MARS INC (US) | 2025-04-16 | — | — | EP | claimed |
| CN-119366522-A | Composition for synergistically preventing and treating banana vascular wilt and application thereof | 南通师范高等专科学校(南通市中小学教师研修中心) | 2025-01-28 | — | — | CN | claimed |
| US-20240400784-A1 | Method for Screening Solvent for Extracting Polyvinyl Chloride, Method for Recycling Waste, Recycled Polyvinyl Chloride, and Composition | LG CHEM, LTD. (KR) | 2024-12-05 | — | — | US | claimed |
| US-20240392094-A1 | Method for Screening Solvent for Polyvinyl Chloride Extraction, Recycling Method for Waste Material, and Recycled Polyvinyl Chloride and Composition | LG CHEM, LTD. (KR) | 2024-11-28 | — | — | US | claimed |
| US-12096775-B2 | Method of stable formulation of microbial and microbe derived products and use of same | Advanced Biological Marketing, Inc. (US) | 2024-09-24 | — | — | US | claimed |
| US-20240306688-A1 | METHOD OF MITIGATING OFF-ODORS | GIVAUDAN SA (CH) | 2024-09-19 | — | — | US | claimed |
| CN-116267946-B | Application of 6-amyl-2H-pyran-2-one in preventing and treating litchi frost epidemic disease | 海南大学 | 2024-08-20 | — | — | CN | claimed |
| EP-1592389-B1 | PIPERAZINE-2-CARBOXAMIDE DERIVATIVES | SERONO LAB (CH) | 2009-04-22 | — | — | EP | claimed |
| US-7105628-B2 | Compositions for golf equipment | ACUSHNET COMPANY (US) | 2006-09-12 | — | — | US | claimed |
| WO-2006052985-A1 | LACTONES AS NEW OXYGENATE FUEL ADDITIVES, FUELS BASED THEREON AND METHODS FOR USING SAME | THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM (US) | 2006-05-18 | — | — | WO | claimed |
| US-20060096158-A1 | Lactones as new oxygenate fuel additives, fuels based thereon and methods for using same | ROBINSON J M | 2006-05-11 | — | — | US | claimed |
| US-20040220378-A1 | Compositions for golf equipment | JPMORGAN CHASE BANK, N.A., AS SUCCESSOR ADMINISTRATIVE AGENT | 2004-11-04 | — | — | US | claimed |
| US-6060507-A | APPLYING FUNGICIDAL 5,6-DIHYDRO-6-PENTYL-2H-PYRAN-2-ONE TO FRUIT, VEGETABLE OR TIMBER CROPS | HORTICULTURE AND FOOD RESEARCH INSTITUTE OF NEW ZEALAND LIMITED (NZ) | 2000-05-09 | — | — | US | claimed |
| US-5919552-A | Coated substrates and methods | XEROX CORPORATION (US) | 1999-07-06 | — | — | US | claimed |
| US-5897961-A | USEFUL FOR INK JET PRINTING AND ELECTROSTATIC PRINTING | XEROX CORPORATION (US) | 1999-04-27 | — | — | US | claimed |
| EP-0743821-A1 | TRICHODERMAS AND METABOLITES AS BIOLOGICAL CONTROL AGENTS | THE HORTICULTURE AND FOOD RESEARCH INSTITUTE OF NEW ZEALAND LIMITED (NZ) | 1996-11-27 | — | — | EP | claimed |
| WO-1995020879-A2 | TRICHODERMAS AND METABOLITES AS BIOLOGICAL CONTROL AGENTS | THE HORTICULTURE AND FOOD RESEARCH INSTITUTE OF NEW ZEALAND LIMITED (NZ) | 1995-08-10 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12575585-B2 | Crumb chocolate flavor compositions | DAGLA, MSMO1, HSD3B2 | MAPT 2972/4885GPR84 3541/4885CTRC 514/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.